T. Rowe Price Investment Management, Inc.

Position in IMCR — Immunocore Holdings plc

CIK 1897612 BALTIMORE, MD

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,031,740

+$26,708,113 QoQ

Shares Held

1,891,600

+116.5% QoQ

Ownership

3.67%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	6,754,846	$1,801,652,525
2	ALNY	Alnylam Pharmaceuticals, Inc.	5,642,173	$1,698,463,338
3	CYTK	Cytokinetics Inc	18,718,498	$1,594,628,844
4	KYMR	Kymera Therapeutics, Inc.	6,257,261	$717,520,118
5	PCVX	Vaxcyte, Inc.	12,207,450	$709,619,068
6	DYN	Dyne Therapeutics, Inc.	30,912,287	$686,561,894
7	CGON	CG Oncology, Inc.	6,616,899	$470,130,673
8	IMNM	Immunome Inc.	19,676,883	$416,953,150

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,031,740	1,891,600	+116.5%	Shares	Sole	2026-05-15
2026-02-28	$98,253,499	3,041,904	—	Shares	Sole	2026-03-06
2025-12-31	$30,323,627	873,628	-87.6%	Shares	Sole	2026-02-17
2025-09-30	$256,631,341	7,063,896	-0.1%	Shares	Sole	2025-11-14
2025-06-30	$221,783,139	7,067,659	+0.2%	Shares	Sole	2025-08-14
2025-03-31	$209,227,440	7,051,818	+5.2%	Shares	Sole	2025-05-14
2024-12-31	$197,656,136	6,700,208	+3.1%	Shares	Sole	2025-02-14
2024-09-30	$202,339,863	6,499,835	+117.2%	Shares	Sole	2024-11-14
2024-06-30	$101,408,131	2,992,273	+307.9%	Shares	Sole	2024-08-14
2024-03-31	$47,684,715	733,611	+95.9%	Shares	Sole	2024-05-15
2023-12-31	$25,590,007	374,561	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.